Tag:

CDC

Latest Headlines

Latest Headlines

Dx Digest: NanoString Technologies expands companion Dx deal with Merck; FDA grants first approval of Zika test for emergency use

In this week's Dx Digest, NanoString Technologies struck a deal with pharma giant Merck to develop a companion diagnostic for the drugmaker's new cancer treatment, the FDA has cleared the first test to screen for the Zika virus and MD Bioscience has rolled out a lab-developed test for Zika, and Belgium's MDxHealth got good news for its prostate cancer test after a leading group of U.S. cancer centers recommended the tool.

Top Senate Democrat grills HHS about opioid panel's alleged ties to industry

About a third of panelists at a Department of Health and Human Services (HHS) meeting on painkiller prescribing had financial ties to companies that make the drugs, a recent report showed. A top Senate Democrat is not pleased with those findings, and he's grilling the HHS about the members' relationships with the industry.

CDC taps uBiome for large-scale microbiome sequencing initiative

The Centers for Disease Control and Prevention (CDC) has hooked up with microbiome sequencing startup uBiome to study hospital-associated infections. At the heart of the collaboration is a major data generation and analysis initiative, for which uBiome will sequence 10,000 stool samples before sifting through the data to learn how the makeup of gut bacteria changes during hospital stays.

CDC calls for proper cleaning of reusable devices amid fallout from duodenoscope safety scare

The federal Centers for Disease Control and Prevention has issued an alert that requests healthcare facilities "arrange for a healthcare professional with expertise in device reprocessing to immediately assess their reprocessing procedures," adding, "(t)his assessment should ensure that reprocessing is done correctly, including allowing enough time for reprocessing personnel to follow all steps recommended by the device manufacturer."

Potency worries prompt GSK flu vaccine recall

To cap off one of the least effective seasons for flu vaccines in recent memory, vaccine producer GlaxoSmithKline announced the recall of all remaining doses of a quadrivalent, affecting roughly 1.7 million jabs.

Quest Diagnostics teams up with CDC for hepatitis research initiative

Quest Diagnostics inked a deal with the Centers for Disease Control and Prevention (CDC) to improve screening, diagnosis and treatment for four strains of viral hepatitis in the U.S., expanding on a previous collaboration and giving the company a boost as it continues to restructure and restore revenue growth.

Quest Diagnostics teams up with CDC for hepatitis research initiative

Quest Diagnostics inked a deal with the Centers for Disease Control and Prevention (CDC) to improve screening, diagnosis and treatment for four strains of viral hepatitis in the U.S., expanding on a previous collaboration and giving the company a boost as it continues to restructure and restore revenue growth.

Team taps Wikipedia for flu forecasting data

The space occupied by Google Flu Trends is becoming more congested. One year after the Centers for Disease Control and Prevention put out a call for ways to use digital data to forecast the flu season, details of the entrants' models are still trickling in as academic papers are published.

Google adds CDC data to Flu Trends model

Google has made the biggest change to its Flu Trends influenza tracking software since it first released the system in 2008. The update incorporates data from the Centers for Disease Control and Prevention in an attempt to improve the accuracy of the model.

Pfizer, Merck pick up hefty vax sales bump with CDC nod in seniors

Pfizer's Prevnar 13, the world's best-selling vaccine, scored a big win Wednesday, nabbing a CDC committee nod for universal use in adults over the age of 65. And once payer coverage kicks in, that's a nod that could be worth $2 billion for Pfizer, analysts say--with Merck's Pneumovax getting a boost, too.